TITLE

A flux of the reds: evolution of active management of the third stage of labour

AUTHOR(S)
Baskett, T. F.
PUB. DATE
September 2000
SOURCE
Journal of the Royal Society of Medicine;Sep2000, Vol. 93 Issue 9, p489
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the implications of ergot on active management of the third stage of childbirth. The first documentation of ergot, which was used to stimulate uterine contractions, was in 1582. However, due to its side effects, the administration before delivery was abandoned in the 19th century. Its application for the treatment of miscarriage and postpartum hemorrhage was emphasized.
ACCESSION #
23100763

 

Related Articles

  • Risk of stroke, gangrene from ergot drug interactions. Wooltorton, Eric // CMAJ: Canadian Medical Association Journal;4/15/2003, Vol. 168 Issue 8, p1015 

    Focuses on dihydroergotamine and ergotamine, which are ergot alkaloids commonly used to treat migraines. Interactions caused by ergot derivatives with several commonly used antibiotic, antiviral and antifungal drugs; How physicians are often unaware of all the medications patients take, and...

  • …and ergot-derived dopamine agonists….  // Reactions Weekly;7/5/2008, Issue 1209, p2 

    The article reports on the recommendation of the European Medicines Agency (EMEA) to revise the product information for ergot-derived dopamine agonists. It wants to include new warnings and contraindications relating to the risk of fibrosis. The agency's Committee for Medicinal Products for...

  • Cabergoline.  // Reactions Weekly;12/8/2012, Issue 1431, p12 

    The article describes the case of a 27-year-old woman who experienced pneumocephalus and cerebrospinal fluid (CSF) rhinorrhoea during treatment with cabergoline for invasive prolactinoma.

  • Cabergoline.  // Reactions Weekly;8/6/2011, Issue 1363, p11 

    The article describes the case of a 56-year-old man who developed aortic and mitral valve regurgitation during treatment with cabergoline for Parkinson's disease.

  • Dopamine receptor agonists.  // Reactions Weekly;Oct2015, Vol. 1571 Issue 1, p82 

    The article presents case report of a patient who developed impulse control disorders during treatment with dopamine agonists.

  • Dopamine receptor agonists.  // Reactions Weekly;9/1/2012, Issue 1417, p20 

    The article describes the case of a 58-year-old man with Parkinson's disease who experienced dopamine dysregulation syndrome and insomnia while undergoing therapy with dopamine receptor agonists.

  • Cabergoline.  // Reactions Weekly;7/20/2013, Issue 1462, p14 

    The article presents a case study about the development of postpartum schizoaffective disorder after receiving cabergoline.

  • Cabergoline.  // Reactions Weekly;Mar2014, Vol. 1490 Issue 1, p11 

    The article presents a case report of a 16-year-old girl who developed immune haemolytic anaemia while receiving cabergoline for prolactinoma.

  • ERGONOVINE. GRIFFITH, H. WINTER // Complete Guide to Prescription & Nonprescription Drugs 2012;2011, p362 

    The article presents information on ergonovine, a drug for excessive post-delivery bleeding, including its dosage, side effects, precautions when administering, and possible interaction with other drugs.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics